{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:42:09Z","timestamp":1790811729659,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Surgical procedures in the heart requires protection of the heart from ischemia\u2013reperfusion injury. Cardioplegia is the primary myocardial protective method in use. Histidine\u2013tryptophan\u2013ketoglutarate (HTK) solution is an intracellular cardioplegic solution that was initially used to preserve organs for transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic electronic search was conducted in July 2021, in four databases; PubMed, Scopus, Web of Science, and Cochrane Library for eligible randomized controlled trials. The results were screened and the eligible trials were identified. Thereafter, the relevant data were extracted and pooled as mean difference or risk ratio, and 95% confidence interval in an inverse variance method using RevMan software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This review included 12 trials (n\u2009=\u20091327). HTK solution has resulted significantly in shorter intensive care unit stay (MD\u2009=\u2009\u2212\u20090.09; 95% CI [\u2212\u20090.15, \u2212\u20090.03], p\u2009=\u20090.006), and shorter hospital stay (MD\u2009=\u2009\u2212\u20090.51; 95% CI [\u2212\u20090.71, \u2212\u20090.31], p\u2009&lt;\u20090.00001). Moreover, the patients who received the HTK solution had significantly lower levels of creatine kinase (after 4\u20137\u00a0h (MD\u2009=\u2009\u2212\u2009157.52; 95% CI [\u2212\u2009272.31, \u2212\u200942.19], p\u2009=\u20090.007), and 24\u00a0h (MD\u2009=\u2009\u2212\u2009136.62; 95% CI [\u2212\u2009267.20, \u2212\u20096.05], p\u2009=\u20090.04)), as well as creatine kinase muscle brain band (after 44\u201348\u00a0h (MD\u2009=\u2009\u2212\u20093.35; 95% CI [\u2212\u20095.69, \u2212\u20091.02], p\u2009=\u20090.005)).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>HTK solution had the same efficacy and safety as other cardioplegic solutions in most of the clinical parameters. Furthermore, the solution showed superiority in fastening the recovery and protecting the myocardium at the biochemical level. HTK solution provides longer myocardial protection; therefore, it limits surgical interruption. HTK solution can be used as an alternative to the currently used cardioplegic solutions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-022-01891-x","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:06:20Z","timestamp":1654002380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Histidine\u2013tryptophan\u2013ketoglutarate solution versus multidose cardioplegia for myocardial protection in cardiac surgeries: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-1677","authenticated-orcid":false,"given":"Muayad","family":"Albadrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"issue":"5","key":"1891_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1590\/S0034-70942005000500012","volume":"55","author":"LM Malbouisson","year":"2005","unstructured":"Malbouisson LM, Santos LM, Auler JO Jr, Carmona MJ. Myocardial protection in cardiac surgery. Rev Bras Anestesiol. 2005;55(5):558\u201374.","journal-title":"Rev Bras Anestesiol"},{"key":"1891_CR2","doi-asserted-by":"crossref","unstructured":"Gunnes S, Jynge P. Fundamentals of the past: cardioplegia: the first period revisited. 2011. p. 15\u201340.","DOI":"10.1007\/978-3-211-85548-5_2"},{"issue":"5","key":"1891_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2007-1022099","volume":"28","author":"HJ Bretschneider","year":"1980","unstructured":"Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg. 1980;28(5):295\u2013302.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"2","key":"1891_CR4","doi-asserted-by":"publisher","first-page":"S661","DOI":"10.1016\/S0003-4975(02)04688-X","volume":"75","author":"DJ Chambers","year":"2003","unstructured":"Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg. 2003;75(2):S661\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"1891_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-2007-1023403","volume":"32","author":"MM Gebhard","year":"1984","unstructured":"Gebhard MM, Preusse CJ, Schnabel PA, Bretschneider HJ. Different effects of cardioplegic solution HTK during single or intermittent administration. Thorac Cardiovasc Surg. 1984;32(5):271\u20136.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"3","key":"1891_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-2007-1020064","volume":"36","author":"RC Gallandat Huet","year":"1988","unstructured":"Gallandat Huet RC, Karliczek GF, van der Heide JN, Brenken U, Mooi B, van der Broeke JJ, et al. Clinical effect of Bretschneider-HTK and St. Thomas cardioplegia on hemodynamic performance after bypass measured using an automatic datalogging database system. Thorac Cardiovasc Surg. 1988;36(3):151\u20136.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"5","key":"1891_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/MAT.0b013e318188b86c","volume":"54","author":"J Liu","year":"2008","unstructured":"Liu J, Feng Z, Zhao J, Li B, Long C. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. ASAIO J (American Society for Artificial Internal Organs: 1992). 2008;54(5):470\u20133.","journal-title":"ASAIO J (American Society for Artificial Internal Organs: 1992)"},{"issue":"4","key":"1891_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0022-5223(19)34192-3","volume":"105","author":"PJ Hendry","year":"1993","unstructured":"Hendry PJ, Labow RS, Keon WJ. A comparison of intracellular solutions for donor heart preservation. J Thorac Cardiovasc Surg. 1993;105(4):667\u201373.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"1891_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/00007890-199710150-00006","volume":"64","author":"K Ku","year":"1997","unstructured":"Ku K, Oku H, Alam MS, Saitoh Y, Nosaka S, Nakayama K. Prolonged hypothermic cardiac storage with histidine\u2013tryptophan\u2013ketoglutarate solution: comparison with glucose-insulin-potassium and University of Wisconsin solutions. Transplantation. 1997;64(7):971\u20135.","journal-title":"Transplantation"},{"issue":"4","key":"1891_CR10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jtcvs.2010.07.011","volume":"141","author":"B Braathen","year":"2011","unstructured":"Braathen B, Jeppsson A, Scherst\u00e9n H, Hagen OM, Vengen \u00d8, Rexius H, et al. One single dose of histidine\u2013tryptophan\u2013ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg. 2011;141(4):995\u20131001.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1891_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.13603","volume":"30","author":"M Trakatelli","year":"2016","unstructured":"Trakatelli M, Barkitzi K, Apap C, Majewski S, De Vries E, group E, et al. Skin cancer risk in outdoor workers: a European multicenter case\u2013control study. J Eur Acad Dermatol Venereol. 2016;30:5\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"1891_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.","journal-title":"PLoS Med"},{"key":"1891_CR13","doi-asserted-by":"crossref","unstructured":"Assessing risk of bias in a randomized trial. Cochrane handbook for systematic reviews of interventions. 2019. p. 205\u201328.","DOI":"10.1002\/9781119536604.ch8"},{"issue":"11","key":"1891_CR14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"7414","key":"1891_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed). 2003;327(7414):557\u201360.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"1","key":"1891_CR16","doi-asserted-by":"publisher","first-page":"E170","DOI":"10.1532\/hsf.3495","volume":"24","author":"I Ali","year":"2021","unstructured":"Ali I, Hassan A, Shokri H, Khorshed R. Efficacy of histidine\u2013tryptophan\u2013ketoglutarate solution versus blood cardioplegia in cardiac surgical procedures: a randomized controlled | parallel group study. Heart Surg Forum. 2021;24(1):E170\u20136.","journal-title":"Heart Surg Forum"},{"key":"1891_CR17","first-page":"192","volume":"77","author":"D Cvetkovic","year":"2018","unstructured":"Cvetkovic D, Kocica M, Soskic L, Vucicevic F, Petrovic O, Jovanovic I, et al. Comparison of Custodiol\u00ae and modified St. Thomas cardioplegia for myocardial protection in coronary artery bypass grafting. Vojnosanit Pregl. 2018;77:192.","journal-title":"Vojnosanit Pregl"},{"issue":"5","key":"1891_CR18","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jtcvs.2019.03.125","volume":"159","author":"A Vivacqua","year":"2020","unstructured":"Vivacqua A, Robinson J, Abbas AE, Altshuler JM, Shannon FL, Podolsky RH, et al. Single-dose cardioplegia protects myocardium as well as traditional repetitive dosing: A noninferiority randomized study. J Thorac Cardiovasc Surg. 2020;159(5):1857-63.e1.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"1891_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/14017431.2013.836241","volume":"47","author":"M Gaudino","year":"2013","unstructured":"Gaudino M, Pragliola C, Anselmi A, Pieroni M, De Paulis S, Leone A, et al. Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery. Scand Cardiovasc J SCJ. 2013;47(6):359\u201367.","journal-title":"Scand Cardiovasc J SCJ"},{"key":"1891_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5455\/aces.20120220105531","volume":"1","author":"I Kammerer","year":"2012","unstructured":"Kammerer I, Nagib R, Hipp G, Premer M, Hansen M, Franke U. Myocardial protection in minimally invasive mitral valve surgery: comparison of the cold-blood cardioplegia of the Bretschneider so-lution and the warm-blood cardioplegia of the Calafiore protocol. Arch Clin Exp Surg (ACES). 2012;1:1.","journal-title":"Arch Clin Exp Surg (ACES)"},{"issue":"3","key":"1891_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1055\/s-0031-1278300","volume":"17","author":"TL Demmy","year":"2008","unstructured":"Demmy TL, Molina JE, Ward HB, Gorton ME, Kouchoukos NT, Schmaltz RA, et al. Custodiol versus Plegisol: a phase 3 multicentre myocardial protection study. Int J Angiol. 2008;17(3):149\u201353.","journal-title":"Int J Angiol"},{"issue":"7","key":"1891_CR22","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1016\/j.transproceed.2005.08.020","volume":"37","author":"A Arslan","year":"2005","unstructured":"Arslan A, Sezgin A, Gultekin B, Ozkan S, Akay T, Uguz E, et al. Low-dose histidine\u2013tryptophan\u2013ketoglutarate solution for myocardial protection. Transpl Proc. 2005;37(7):3219\u201322.","journal-title":"Transpl Proc"},{"issue":"4","key":"1891_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0188-4409(01)00296-X","volume":"32","author":"G Careaga","year":"2001","unstructured":"Careaga G, Salazar D, T\u00e9llez S, S\u00e1nchez O, Borrayo G, Arg\u00fcero R. Clinical impact of histidine\u2013ketoglutarate\u2013tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients. Arch Med Res. 2001;32(4):296\u20139.","journal-title":"Arch Med Res"},{"issue":"1","key":"1891_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-2007-1013985","volume":"38","author":"F Beyersdorf","year":"1990","unstructured":"Beyersdorf F, Krause E, Sarai K, Sieber B, Deutschl\u00e4nder N, Zimmer G, et al. Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery. Thorac Cardiovasc Surg. 1990;38(1):20\u20139.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"5","key":"1891_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.21470\/1678-9741-2019-0327","volume":"35","author":"I Mercan","year":"2020","unstructured":"Mercan I, Dereli Y, Topcu C, Tanyeli O, Isik M, Gormus N, et al. Comparison between the effects of Bretschneider\u2019s HTK solution and cold blood cardioplegia on systemic endothelial functions in patients who undergo coronary artery bypass surgery: a prospective randomized and controlled trial. Braz J Cardiovasc Surg. 2020;35(5):634\u201343.","journal-title":"Braz J Cardiovasc Surg"},{"key":"1891_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jocs.15397","volume":"36","author":"A Reynolds","year":"2021","unstructured":"Reynolds A, Asopa S, Modi A, King N. HTK versus multidose cardioplegias for myocardial protection in adult cardiac surgery: a meta-analysis. J Card Surg. 2021;36:1\u201310.","journal-title":"J Card Surg"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01891-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-01891-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01891-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:16:03Z","timestamp":1654002963000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-01891-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-01891-x","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not in need because this type of reserch is a meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}